Clinical Trial

A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to investigate the efficacy and safety of the lifileucel regimen in participants with previously treated endometrial cancer.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2024-06-25; most recent amendment 2025-10-29.
Status change: Not Yet Recruiting → Recruiting 2024-09-26
Trial Details
NCT Number NCT06481592
Lead Sponsor Iovance Biotherapeutics, Inc.
Conditions Endometrial Cancer
Enrollment 60 participants
Start Date 2024-10-29
Primary Completion 2028-05 (estimated)
Study Completion 2029-11 (estimated)
Updated on ClinicalTrials.gov 2025-10-30